Pearl River, NY, United States of America

Kena Anne Swanson

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 9.1

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Kena Anne Swanson: A Pioneer in Biopharmaceutical Innovations

Introduction

Kena Anne Swanson, an accomplished inventor based in Pearl River, NY, has made significant contributions to the field of biopharmaceuticals. With a total of seven patents to her name, her work primarily focuses on the development of vaccines and treatments for viral infections, particularly those caused by respiratory viruses.

Latest Patents

Among her latest patents are groundbreaking innovations in respiratory syncytial virus (RSV) and coronavirus research. One notable patent details RSV F protein mutants, which encompass nucleic acids or vectors that encode these mutants, as well as various compositions and their applications. This work holds promise for advancing vaccine development against RSV. Another pivotal patent concerns a coronavirus vaccine, specifically targeting SARS-CoV-2. It outlines methods and agents designed to prevent or treat coronavirus infection, including the administration of RNA that encodes a protein associated with the spike protein of the virus, thereby inducing robust immune responses.

Career Highlights

Kena has built a distinguished career in the biopharmaceutical industry, contributing her expertise to renowned companies such as Pfizer Corporation and BioNTech SE. Her dedication to advancing medical science through innovative research has positioned her as a leader in her field, influencing the direction of vaccine research and development.

Collaborations

Throughout her career, Kena has collaborated with notable scientists and researchers, including Ye Che and Philip R. Dormitzer. These collaborations have further amplified the impact of her work, allowing her to explore new ideas and bring innovative solutions to pressing health challenges in the realm of viral infections.

Conclusion

Kena Anne Swanson stands out as a formidable inventor and innovator. Her patents not only reflect her commitment to improving public health but also symbolize the ongoing evolution of biopharmaceutical technologies. As her work continues to advance, it promises to play a crucial role in combating viral diseases and enhancing global health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…